CA2009946A1 - Concentre de facteur de von willebrand purifie, pasteurise, et procede de preparation - Google Patents

Concentre de facteur de von willebrand purifie, pasteurise, et procede de preparation

Info

Publication number
CA2009946A1
CA2009946A1 CA2009946A CA2009946A CA2009946A1 CA 2009946 A1 CA2009946 A1 CA 2009946A1 CA 2009946 A CA2009946 A CA 2009946A CA 2009946 A CA2009946 A CA 2009946A CA 2009946 A1 CA2009946 A1 CA 2009946A1
Authority
CA
Canada
Prior art keywords
von willebrand
preparation
willebrand factor
pasteurized
factor concentrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2009946A
Other languages
English (en)
Other versions
CA2009946C (fr
Inventor
Norbert Heimburger
Gerhard Kumpe
Klaus Wellner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Behring GmbH Deutschland
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6374025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2009946(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2009946A1 publication Critical patent/CA2009946A1/fr
Application granted granted Critical
Publication of CA2009946C publication Critical patent/CA2009946C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
CA002009946A 1989-02-14 1990-02-13 Concentre de facteur de von willebrand purifie, pasteurise, et procede de preparation Expired - Fee Related CA2009946C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3904354.1 1989-02-14
DE3904354A DE3904354A1 (de) 1989-02-14 1989-02-14 Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
CA2009946A1 true CA2009946A1 (fr) 1990-08-14
CA2009946C CA2009946C (fr) 2000-04-11

Family

ID=6374025

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002009946A Expired - Fee Related CA2009946C (fr) 1989-02-14 1990-02-13 Concentre de facteur de von willebrand purifie, pasteurise, et procede de preparation

Country Status (12)

Country Link
US (1) US6239261B1 (fr)
EP (1) EP0383234B1 (fr)
JP (1) JP2930243B2 (fr)
KR (1) KR0149999B1 (fr)
AT (1) ATE114669T1 (fr)
AU (1) AU638969B2 (fr)
CA (1) CA2009946C (fr)
DE (2) DE3904354A1 (fr)
DK (1) DK0383234T3 (fr)
ES (1) ES2066020T3 (fr)
IE (1) IE900511L (fr)
PT (1) PT93128B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465624B1 (en) 1997-02-27 2002-10-15 Baxter Aktiengesellschaft Purification of von-Willebrand factor by cation exchanger chromatography
US6579723B1 (en) 1997-02-27 2003-06-17 Baxter Aktiengesellschaft Method of recovering highly purified vWF or factor VIII/vWF-complex

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2644064B1 (fr) * 1989-02-17 1994-05-27 Aquitaine Dev Transf Sanguine Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
CA2634663C (fr) 1999-02-22 2009-08-25 University Of Connecticut Nouvelles formulations de facteur viii sans albumine
DE10022092A1 (de) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
US7365173B2 (en) * 2002-02-04 2008-04-29 American National Red Cross Method for the production of pure virally inactivated butyrylcholinesterase
DE10246125A1 (de) * 2002-10-01 2004-04-15 Aventis Behring Gmbh Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
AU2005225000A1 (en) * 2004-03-04 2005-09-29 Wyeth Lyophilization method to improve excipient crystallization
FR2874216B1 (fr) 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
JP2008512098A (ja) 2004-09-07 2008-04-24 アーケミックス コーポレイション フォン・ビルブラント因子に対するアプタマー、および血栓性疾患の処置剤としてのその使用
JP2008512097A (ja) * 2004-09-07 2008-04-24 アーケミックス コーポレイション アプタマー医薬品化学
WO2008150495A2 (fr) * 2007-06-01 2008-12-11 Archemix Corp. Formulations d'aptamère vwf et procédés d'utilisation
EP2385825B1 (fr) 2008-11-07 2018-10-10 University of Connecticut Formulation de facteur viii
JP6583766B2 (ja) * 2015-02-02 2019-10-02 学校法人北里研究所 タンパク質分離方法、タンパク質分析方法、及びタンパク質分離キット
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
CN105622747A (zh) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 一种vWF活性保护液
CN105541997A (zh) * 2016-02-04 2016-05-04 江西博雅生物制药股份有限公司 一种高纯度和高活性血管性血友病因子的制备工艺
CN105622746A (zh) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 一种从冷沉淀提取凝血因子ⅷ的废料中提取人血管性血友病因子的制备工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4278594A (en) 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
GB2079292A (en) 1980-07-05 1982-01-20 Speywood Lab Ltd Blood Clotting Factor Production
US4361509A (en) 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
GB8403473D0 (en) 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
DE3707213A1 (de) * 1987-03-06 1988-09-15 Behringwerke Ag Verfahren zur herstellung von faktor viii:c-mangelplasma und ein so erhaltenes mangelplasma
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465624B1 (en) 1997-02-27 2002-10-15 Baxter Aktiengesellschaft Purification of von-Willebrand factor by cation exchanger chromatography
US6579723B1 (en) 1997-02-27 2003-06-17 Baxter Aktiengesellschaft Method of recovering highly purified vWF or factor VIII/vWF-complex

Also Published As

Publication number Publication date
JPH02264799A (ja) 1990-10-29
PT93128A (pt) 1990-08-31
ES2066020T3 (es) 1995-03-01
AU638969B2 (en) 1993-07-15
IE900511L (en) 1990-08-14
AU4933990A (en) 1990-08-30
JP2930243B2 (ja) 1999-08-03
CA2009946C (fr) 2000-04-11
EP0383234A3 (fr) 1991-08-07
ATE114669T1 (de) 1994-12-15
US6239261B1 (en) 2001-05-29
PT93128B (pt) 1995-12-29
KR0149999B1 (ko) 1998-08-17
KR900012615A (ko) 1990-09-01
DK0383234T3 (da) 1995-05-01
DE59007785D1 (de) 1995-01-12
EP0383234A2 (fr) 1990-08-22
DE3904354A1 (de) 1990-08-16
EP0383234B1 (fr) 1994-11-30

Similar Documents

Publication Publication Date Title
AU638969B2 (en) Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof
AU5557994A (en) Process for producing an undernatured whey protein concentrate
HU9201130D0 (en) Multifunctional, water dispergeable cristallizing substance
HU895836D0 (en) Process for the preparation of carrier proteins
GR3023203T3 (en) Treatment for asthma.
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
ZA898788B (en) Method for purification of acids from materials comprising acid and salt
CA2123685A1 (fr) Medicament stimulant la croissance nerveuse chez les mammiferes
IL69927A (en) Process for the pasteurization of antihemophilic cryoprecipitate(ahc),and antihemophilic cryoprecipitate prepared thereby
ZA932843B (en) A method of producing a factor VIII preparation
AU3350089A (en) Antihypertensive hyperimmune milk, production, composition, and use
AU3239184A (en) Process for the pasteurization of human plasma
EP0571771A3 (en) Method of inactivation of viruses in proteinic preparations
AU582416B2 (en) Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms
PT94917A (pt) Processo para a preparacao de factor viii estavel
EP0281089A3 (en) Process for the preparation of factor viii:c deficient plasma, and deficient plasma obtained therwith
GB2176188B (en) Process for producing 2,6-naphthalenediol and 2,6-diacetoxynaphthalene
DE3264621D1 (en) Vincamine cyclamate, process for its preparation and medicaments containing it
CS390989A3 (en) Pseudoprimycin complex, its components and their addition salts with acidsand process for preparing thereof
ZA895931B (en) An improved process for the preparation of n,n'-bis=(alkozyalkyl)-pyridine-2,4-dicarboxamides
BG42540A1 (en) Method for producing milk protein concentrate
CS789587A1 (en) Process for treatment n-phenyl-n-/1,3-dimethylbutyl/-p-phenylendiamine melt
YU123388A (en) Process for producing bio yoghurt and bio sour milk

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed